Inhabitants well being expertise firm Colour Well being introduced the appointment of Dr. Rebecca Miksad as chief medical officer and Josh Sturm as chief income officer.
Miksad is a medical oncologist and head of Boston College College of Medication’s Excessive Danger Most cancers Genetics Clinic and previously held the place of senior medical director at oncology-focused digital well being firm Flatiron Well being.
She’s going to oversee Colour’s medical and medical features, together with the event of its Digital Most cancers Clinic.
Sturm will concentrate on increasing Colour’s partnerships. He previously served as vp at digital musculoskeletal firm Hinge Well being. He was additionally the vp at Surescripts and Cigna-owned on-line pharmacy and pharmacy profit supervisor Specific Scripts.
“Josh and Rebecca have very important on-the-ground expertise in affected person and buyer relationships which are invaluable in telling the story of what working with an organization like Colour can do for each corporations and particular person sufferers,” Othman Laraki, CEO of Colour Well being, stated in a press release.
“Their experience personifies Colour’s work, taking particular person connections and scaling them into well being advantages that attain hundreds of individuals, and units us as much as proceed increasing the attain and high quality of our companies for our clients.”
Digital cardiac and lung-disease well being startup Eko Well being is including Brent D. Lang to its board of administrators.
Lang is a former Olympic gold medalist and was chairman and CEO of Vocera Communications. He led Vocera by its development, IPO and $3 billion acquisition by Stryker.
“Brent’s wealth of expertise in healthcare expertise and firm constructing, mixed with a deep dedication to enhancing affected person outcomes, makes him the proper companion for Eko as we proceed to assist clinicians diagnose cardiopulmonary ailments earlier and with higher accuracy,” Connor Landgraf, CEO of Eko Well being, stated in a press release. “We’re thrilled to welcome him to our Board.”
Healthcare expertise firm Medtronic has employed Dr. James Porter as chief medical officer of robotic surgical applied sciences and digital applied sciences inside the surgical enterprise, which is a part of the corporate’s Medical Surgical Portfolio.
Porter is a training urologic surgeon specializing in prostate, kidney most cancers and urinary constructive procedures. The corporate says he’s “a acknowledged chief among the many international surgical neighborhood and one of many high 5 robotic surgical procedure practitioners within the U.S.”
He’s additionally the medical director of robotic surgical procedure at Windfall Swedish in Seattle, Washington.
“Medtronic is privileged to welcome such a famend doctor to our enterprise, and we stay up for Dr. Porter’s contributions as CMO of our robotic and digital divisions as we execute our technique to scale and regularly advance our capabilities to satisfy buyer wants and positively impression sufferers all over the world,” Rajit Kamal, basic supervisor and vp of Robotic Surgical Applied sciences inside the surgical enterprise at Medtronic, stated in a press release.”
